Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring
Javed Butler, MD, MBA, MPH
John P. Boehmer, MD
Is There Still Any Role for Plasma Exchange in AAV?
Vladimir Tesar, MD
Michael Walsh, MD
Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients
David Jayne, MD
Challenges in the Early Diagnosis of AAV
Duvuru Geetha, MD
Treating Iron Deficiency in Patients with HFrEF: A Review of the Recent Data for IV Iron Replacement Therapy
Stefan D. Anker, MD, PhD
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Piotr Ponikowski, MD, PhD, FESC, FHFA
Best Practices in Fluid Management During CKRT
Marlies Ostermann, MD
Javier Neyra, MD, MSCS
Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI
Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP
The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients
Rinaldo Bellomo, MBBS, MD, FRACP
Reducing Morbidity and Mortality in Patients with CKD in T2D: New Late-Breaking Data
Pam R. Taub, MD, FACC, FASPC
George L. Bakris, MD, FAHA, FASN
Gerasimos S. Filippatos, MD, FESC, FHFA, FHFSA(h)
What Are We Missing? Iron Deficiency in Heart Failure
Peter van der Meer, MD, PhD
Anemia in Chronic Kidney Disease: Improved Patient Outcomes Needed STAT!
Charles P. Vega, MD
Rajeev Raghavan, MD, M.Ed, FASN
Maximally Tolerated or Suboptimal Therapy? Clinical Perspectives on Rechallenging RAASi Therapy
Ileana L. Piña, MD, MPH, FAHA, FACC
Patrick Rossignol, MD, PhD
Worsening Heart Failure: The How, Why, and When of Novel Treatment Options
Shelley Zieroth, MD
Looking Beyond Diabetes: The Role of SGLT2i and MRAs in Cardiorenal Disease
Mikhail Kosiborod, MD
The Role of Potassium Binders in Optimal HF Management: Discussing the DIAMOND Study
Bertram Pitt, MD
A New Option for Cardiorenal Protection for Patients with CKD in T2D
Javier Morales, MD, FACP, FACE
Angela Yee-Moon Wang, MD, FACP, FACE
